Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRadiation Oncology Physician in Madison, WI
NPI: 1053576926Primary Practice Location
SSM Health Cancer Center
1104 John Nolen Dr, Madison, WI
Primary Employer
SSM Health Cancer Center
ssmhealth.com
HQ Phone
Get M.D. Timothy's Phone Numberphone_androidMobile
Get M.D. Timothy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
WI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77336Radiation therapy consultation per week | 76 | 282 |
| 2 | 77014Ct scan guidance for insertion of radiation therapy fields | 75 | 843 |
| 3 | 77427Radiation treatment management, 5 treatment sessions | 74 | 264 |
| 4 | 77300Calculation of radiation therapy dose | 73 | 188 |
| 5 | 77263Complex radiation therapy planning | 72 | 77 |
Advancements in unresectable melanoma: a multidisciplinary perspective.
Authors: Jeffrey Sosman, Mary Martini, Jeffrey Wayne, Maria Colavincenzo, Sunandana Chandra, Kurt Lu, Timothy Kuzel, Jeffrey Wayne
Journal: Melanoma Manag
Publication Date: 2016-08-16
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer.
Authors: Michelle Gentile, Comron Hassanzadeh, Nisha Mohindra, Timothy Sita, Clifford Robinson, Pamela Samson, Michael Roach, Saiama Waqar
Publication Date: 2020-12-07
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
Authors: Adithya Chennamadhavuni, Nanmeng Yu, Muhammad Furqan, Lawrence Feldman, Timothy Sita, Melissa Yan
Journal: Transl Lung Cancer Res
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, RADIATION: Prophylactic Cranial Irradiation
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, RADIATION: Stereotactic Body Radiation Therapy
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Pemetrexed Disodium, DRUG: Erlotinib Hydrochloride, RADIATION: Stereotactic Body Radiation Therapy (SBRT), RADIATION: Intensity-Modulated Radiation Therapy (IMRT), RADIATION: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
